Possible Role of Metabolite in Flosequinan-Related Mortality*
- 1 December 1995
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (6) , 396-403
- https://doi.org/10.2165/00003088-199529060-00002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetics, Safety, and Tolerability of Flosequinan in Patients with Hepatic DysfunctionJournal of Pharmaceutical Sciences, 1994
- Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.1993
- Pharmacokinetic Profile of Flosequinan in Patients with Compromised Renal FunctionJournal of Pharmaceutical Sciences, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humansAntimicrobial Agents and Chemotherapy, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976